- Home
- ACXP vs EKSO Comparison
ACXP vs EKSO Comparison
Compare ACXP & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- EKSO
- Stock Information
- Founded
- ACXP 2017
- EKSO 2005
- Country
- ACXP United States
- EKSO United States
- Employees
- ACXP N/A
- EKSO N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- ACXP Health Care
- EKSO Health Care
- Exchange
- ACXP Nasdaq
- EKSO Nasdaq
- Market Cap
- ACXP 8.4M
- EKSO 7.7M
- IPO Year
- ACXP 2021
- EKSO N/A
- Fundamental
- Price
- ACXP $0.31
- EKSO $3.49
- Analyst Decision
- ACXP Strong Buy
- EKSO Strong Buy
- Analyst Count
- ACXP 2
- EKSO 2
- Target Price
- ACXP $10.00
- EKSO $34.75
- AVG Volume (30 Days)
- ACXP 920.6K
- EKSO 142.8K
- Earning Date
- ACXP 08-12-2025
- EKSO 07-28-2025
- Dividend Yield
- ACXP N/A
- EKSO N/A
- EPS Growth
- ACXP N/A
- EKSO N/A
- EPS
- ACXP N/A
- EKSO N/A
- Revenue
- ACXP N/A
- EKSO $14,651,000.00
- Revenue This Year
- ACXP N/A
- EKSO $0.20
- Revenue Next Year
- ACXP N/A
- EKSO $42.29
- P/E Ratio
- ACXP N/A
- EKSO N/A
- Revenue Growth
- ACXP N/A
- EKSO N/A
- 52 Week Low
- ACXP $0.29
- EKSO $2.73
- 52 Week High
- ACXP $2.39
- EKSO $19.20
- Technical
- Relative Strength Index (RSI)
- ACXP 33.75
- EKSO 44.83
- Support Level
- ACXP $0.30
- EKSO $3.30
- Resistance Level
- ACXP $0.50
- EKSO $5.60
- Average True Range (ATR)
- ACXP 0.05
- EKSO 0.46
- MACD
- ACXP -0.02
- EKSO -0.02
- Stochastic Oscillator
- ACXP 7.86
- EKSO 13.38
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.